Cited by 174Nutrition and Health in AgingPancreatic and Hepatic Oncology ResearchMuscle Physiology and Disorders

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review

Open access

Ozola Zalite, I., Zykus, R., Francisco Gonzalez, M., Saygili, F., Pukitis, A., Gaujoux, S., Charnley, R.M., Lyadov, V.·2015·Pancreatology

DOI 10.1016/j.pan.2014.11.006

Open this paper in CoChat — free account

Abstract

Background/objectives Cachexia affects ∼ 80% of pancreatic cancer patients. An international consensus defines cachexia as an ongoing loss of skeletal muscle mass (sarcopenia) with or without loss of fat, which impairs body functioning and cannot be reversed by conventional nutritional measures. Weight loss percentage and elevated inflammation markers have been employed to define this condition earlier. This review aimed to assess the prevalence and consequences of cachexia and sarcopenia on survival in patients with pancreatic ductal adenocarcinoma. Methods The systematic review was performed by searching the articles with preset terms published in PubMed and Cochrane Database until December 2013. After identifying relevant titles, abstracts were read and eligible articles data retrieved on preformatted sheets. The prevalence and impact of sarcopenia/cachexia on survival was evaluated. Results In total 1145 articles were retrieved, only 10 were eligible. Definitions of cachexia and sarcopenia were heterogeneous. In patients with normal weight (BMI 18.5-24.9 kg/m(2)) the prevalence of sarcopenia ranged from 29.7 to 65%. In overweight or obese patients (BMI >25 kg/m(2)) were 16.2%-67%. Sarcopenia alone was not demonstrated to be an independent factor of decreased survival, although obese sarcopenic patients were shown to have significantly worse survival in two studies. Conclusions Impact of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma is currently understudied in the available literature. Definitive association between cachexia and survival cannot be drawn from available studies, although weight loss and sarcopenic obesity might be considered as poor prognostic factors. Further prospective trials utilizing the consensus definition of cachexia and including other confounding factors are needed to investigate the impact of cachexia and sarcopenia on survival in pancreatic adenocarcinoma.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.pan.2014.11.006

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I. G., Bruera, E. D., Fainsinger, R. L., Jatoi, A., Loprinzi, C. L., Macdonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 6,020
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
The Loss of Skeletal Muscle Strength, Mass, and Quality in Older Adults: The Health, Aging and Body Composition Study
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
Martin, L., Birdsell, L., Macdonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R. A., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,761
Prognostic effect of weight loss prior tochemotherapy in cancer patients
DeWys, W. D., Begg, C. B., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,350
Cachexia: a new definition.
Evans, W., Morley, J., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,341
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
Prado, C. M. M., Baracos, V. E., McCargar, L. J., Reiman, T., Mourtzakis, M., Tonkin, K. S., Mackey, J. R., Koski, S. L., Pituskin, E., & Sawyer, M. B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2242 · Cited by 1,125
Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women
Delmonico, M. J., Harris, T. B., Lee, J., Visser, M., Nevitt, M., Kritchevsky, S. B., Tylavsky, F. A., Newman, A. B., & for the Health, A. A. B. C. S. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01140.x · Cited by 819
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis.
Fearon, K., Voss, A., & Hustead, D. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1345 · Cited by 739

Show all 34 references

Sorted by citations

Early Detection of Pancreatic Cancer: Opportunities and Challenges
Singhi, A. D., Koay, E. J., Chari, S. T., & Maitra, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.259 · Cited by 841
Early detection of pancreatic cancer
Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482
Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS)
Gianotti, L. V., Besselink, M. G., Sandini, M., Hackert, T., Conlon, K. C., Gerritsen, A., Griffin, O. M., Fingerhut, A. L., Probst, P., Hilal, M. A., et al. (2018) · Surgery · doi:10.1016/j.surg.2018.05.040 · Cited by 286
Self-citation
Prognostic Value of Sarcopenia in Lung Cancer
Yang, M. J., Shen, Y., Tan, L., & Li, W. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.04.115 · Cited by 257
The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma
Rollins, K. E., Tewari, N., Ackner, A., Awwad, A., Madhusudan, S., Macdonald, I. A., Fearon, K. C. H., & Lobo, D. N. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.08.005 · Cited by 212
Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis
Mintziras, I., Miligkos, M., Wächter, S., Manoharan, J., Maurer, E., & Bartsch, D. K. (2018) · International Journal of Surgery · doi:10.1016/j.ijsu.2018.09.014 · Cited by 209
Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs
Barreto, R., Waning, D. L., Gao, H., Liu, Y., Zimmers, T. A., & Bonetto, A. (2016) · Oncotarget · doi:10.18632/oncotarget.9779 · Cited by 205
Three cachexia phenotypes and the impact of fat‐only loss on survival in FOLFIRINOX therapy for pancreatic cancer
Kays, J. K., Shahda, S., Stanley, M., Bell, T. M., O'Neill, B. H., Kohli, M. D., Couch, M. E., Koniaris, L. G., & Zimmers, T. A. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12307 · Cited by 152
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer
Sandini, M., Patiño, M., Ferrone, C. R., Alvarez-Pérez, C. A., Honselmann, K. C., Paiella, S., Catania, M., Riva, L., Tedesco, G., Casolino, R., et al. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2018.0979 · Cited by 138
Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for Surgery
Adams, D. W., Gurwara, S., Silver, H. J., Horst, S., Beaulieu, D. B., Schwartz, D. A., & Seidner, D. L. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001128 · Cited by 136
A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer
Sandini, M., Bernasconi, D. P., Fior, D., Molinelli, M., Ippolito, D., Nespoli, L. C., Caccialanza, R., & Gianotti, L. V. (2016) · Nutrition · doi:10.1016/j.nut.2016.04.002 · Cited by 130
Pancreatic cancer in 2021: What you need to know to win
Tonini, V., & Zanni, M. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i35.5851 · Cited by 133
Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia
Arai, H., Maeda, K., Wakabayashi, H., Naito, T., Konishi, M., Assantachai, P., Auyeung, W. T., Chalermsri, C., Chen, W., Chew, J. L., et al. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13323 · Cited by 128
Sarcopenia associates with increased hospitalization rates and reduced survival in patients with chronic pancreatitis
Olesen, S. S., Büyükuslu, A., Køhler, M., Rasmussen, H. H., & Drewes, A. M. (2019) · Pancreatology · doi:10.1016/j.pan.2019.01.006 · Cited by 117
Advances in the management of pancreatic cancer
Chiaro, M. D., Sugawara, T., Karam, S. D., & Messersmith, W. A. (2023) · BMJ · doi:10.1136/bmj-2022-073995 · Cited by 118
Pancreatic cancer—A disease in need: Optimizing and integrating supportive care
Moffat, G. T., Epstein, A. S., & O'Reilly, E. M. (2019) · Cancer · doi:10.1002/cncr.32423 · Cited by 100
Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapy
Hendifar, A. E., Chang, J. I., Huang, B. Z., Tuli, R., & Wu, B. U. (2018) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2017.11.10 · Cited by 94
Progressive Resistance Training to Impact Physical Fitness and Body Weight in Pancreatic Cancer Patients
Wiskemann, J., Clauss, D., Tjaden, C., Hackert, T., Schneider, L., Ulrich, C. M., & Steindorf, K. (2019) · Pancreas · doi:10.1097/mpa.0000000000001221 · Cited by 101
Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma
Gruber, E. S., Jomrich, G., Tamandl, D., Gnant, M., Schindl, M., & Sahora, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215915 · Cited by 93
Prognostic and predictive factors in pancreatic cancer
Dell’Aquila, E., Fulgenzi, C. A. M., Minelli, A., Citarella, F., Stellato, M., Pantano, F., Russano, M., Cursano, M. C., Napolitano, A., Zeppola, T., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27518 · Cited by 101
Sarcopenia in pancreatic cancer – effects on surgical outcomes and chemotherapy
Chan, M. Y., & Chok, K. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v11.i7.527 · Cited by 94
Skeletal muscle mass is associated with severe dysphagia in cancer patients
Wakabayashi, H., Matsushima, M., Uwano, R., Watanabe, N., Oritsu, H., & Shimizu, Y. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12052 · Cited by 87
The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma
Nishikawa, D., Hanai, N., Suzuki, H., Koide, Y., Beppu, S., & Hasegawa, Y. (2018) · ORL · doi:10.1159/000485515 · Cited by 85
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
Basile, D., Parnofiello, A., Vitale, M. G., Cortiula, F., Gerratana, L., Fanotto, V., Lisanti, C., Pelizzari, G., Ongaro, E., Bartoletti, M., et al. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12368 · Cited by 84
When the Loss Costs Too Much: A Systematic Review and Meta-Analysis of Sarcopenia in Head and Neck Cancer
Hua, X., Liu, S., Liao, J., Wen, W., Long, Z., Lu, Z.-J., Guo, L., & Lin, H.-X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01561 · Cited by 89
L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patients
Portal, D., Hofstetter, L., Eshed, I., Lantsman, C. D., Sella, T., Urban, D., Onn, A., Bar, J., & Segal, G. (2019) · Cancer Management and Research · doi:10.2147/cmar.s195869 · Cited by 88
Predictors of Pancreatic Cancer–Associated Weight Loss and Nutritional Interventions
Nemer, L., Krishna, S. G., Shah, Z. K., Conwell, D. L., Cruz‐Monserrate, Z., Dillhoff, M. E., Guttridge, D. C., Hinton, A. M., Manilchuk, A., Pawlik, T. M., et al. (2017) · Pancreas · doi:10.1097/mpa.0000000000000898 · Cited by 82
Nutrition in Pancreatic Cancer: A Review
Gärtner, S., Krüger, J., Aghdassi, A. A., Steveling, A., Simon, P., Lerch, M. M., & Mayerle, J. V. (2015) · Gastrointestinal Tumors · doi:10.1159/000442873 · Cited by 80
Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population
Meyerhardt, J. A., Kroenke, C. H., Prado, C. M. M., Kwan, M. L., Castillo, A., Weltzien, E. K., Feliciano, E. M. C., Xiao, J., & Caan, B. J. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0145 · Cited by 82
Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study
Kim, I.-H., Choi, M. H., Lee, I. S., Hong, T. H., & Lee, M. A. (2021) · BMC Cancer · doi:10.1186/s12885-020-07753-w · Cited by 77
Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients
Ramacciato, G., Nigri, G. R., Petrucciani, N., Pinna, A. D., Ravaioli, M., Jovine, E., Minni, F., Grazi, G. L., Chirletti, P., Tisone, G., et al. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5123-5 · Cited by 77
Myosteatosis is associated with poor physical fitness in patients undergoing hepatopancreatobiliary surgery
West, M. A., van Dijk, D. P. J., Gleadowe, F., Reeves, T., Primrose, J. M., Hilal, M. A., Edwards, M., Jack, S., Rensen, S. S., Grocott, M. P. W., et al. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12433 · Cited by 74
Enhanced recovery after surgery programmes in older patients undergoing hepatopancreatobiliary surgery: what benefits might prehabilitation have?
Bongers, B., Dejong, C., & den Dulk, M. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.03.211 · Cited by 69
Emerging signaling mediators in the anorexia–cachexia syndrome of cancer
Talbert, E. E., & Guttridge, D. C. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.01.004 · Cited by 74
Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer
Griffin, O. M., Duggan, S. N., Ryan, R. S., McDermott, R., Geoghegan, J., & Conlon, K. C. (2019) · Pancreatology · doi:10.1016/j.pan.2019.07.039 · Cited by 68
Sarcopenia and survival in patients undergoing pancreatic resection
Onesti, J. K., Wright, G. P., Kenning, S. E., Tierney, M. T., Davis, A. T., Doherty, M. G., & Chung, M. H. (2016) · Pancreatology · doi:10.1016/j.pan.2016.01.009 · Cited by 58
Nutritional management of older adults with gastrointestinal cancers: An International Society of Geriatric Oncology (SIOG) review paper
Mislang, A. R., Donato, S. D., Hubbard, J. M., Krishna, L. K. R., Mottino, G., Bozzetti, F., & Biganzoli, L. (2018) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2018.01.003 · Cited by 61
Resistance Training Impact on Mobility, Muscle Strength and Lean Mass in Pancreatic Cancer Cachexia: A Randomized Controlled Trial
Kamel, F. H., Basha, M. A., Alsharidah, A. S., & Salama, A. B. (2020) · Clinical Rehabilitation · doi:10.1177/0269215520941912 · Cited by 52
Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation
Naumann, P., Eberlein, J., Farnia, B., Liermann, J., Hackert, T., Debus, J., & Combs, S. E. (2019) · Cancers · doi:10.3390/cancers11111655 · Cited by 54
Sarcopenia as a public health problem
Bruyère, O., Beaudart, C., Locquet, M., Buckinx, F., Pétermans, J., & Reginster, J.-Y. (2016) · European Geriatric Medicine · doi:10.1016/j.eurger.2015.12.002 · Cited by 54
Underrecognition of Malnutrition in Advanced Cancer: The Role of the Dietitian and Clinical Practice Variations
Aktaş, A., Walsh, D., Galang, M., O’Donoghue, N., Rybicki, L. A., Hullihen, B., & Schleckman, E. (2016) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909116639969 · Cited by 51
F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities
Sukari, A. W., Muqbil, I., Mohammad, R. M., Philip, P. A., & Azmi, A. S. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.01.002 · Cited by 52
Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches
Cencioni, C., Trestini, I., Piro, G., Bria, E., Tortora, G., Carbone, C., & Spallotta, F. (2022) · Nutrients · doi:10.3390/nu14081542 · Cited by 51
Prognostic value of myosteatosis and sarcopenia for elderly patients with colorectal cancer: A large-scale double-center study
Chen, W., Shen, Z.-L., Zhang, F., Zhang, X.-Z., Chen, W.-H., Yan, X., Zhuang, C., Chen, X.-L., & Yu, Z. (2022) · Surgery · doi:10.1016/j.surg.2022.05.031 · Cited by 44
Citrus unshiu peel extract alleviates cancer-induced weight loss in mice bearing CT-26 adenocarcinoma
Kim, A., Im, M., Gu, M. J., & Yeul, J. (2016) · Scientific Reports · doi:10.1038/srep24214 · Cited by 43
Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations
Sobocki, B. K., Kaźmierczak-Siedlecka, K., Folwarski, M., Hawryłkowicz, V., Makarewicz, W., & Stachowska, E. (2021) · Nutrients · doi:10.3390/nu13124425 · Cited by 43
Borderline resectable pancreatic cancer. Challenges and controversies
Sabater-Orti, L., Forner, E. M., Roselló, S., Dorcaratto, D., Garcés‐Albir, M., Huerta, M., Roda, D., Gómez-Mateo, M. C., Ferrández‐Izquierdo, A., Darder, A., et al. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.06.006 · Cited by 42
Cachexia, dietetic consultation, and survival in patients with pancreatic and periampullary cancer: A multicenter cohort study
Latenstein, A. E. J., Dijksterhuis, W. P. M., Mackay, T. M., Beijer, S., van Eijck, C. H. J., de Hingh, I. H. J. T., Molenaar, I. Q., van Oijen, M. G. H., van Santvoort, H. C., de van der Schueren, M. A. E., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3556 · Cited by 41
Exercise Medicine in the Management of Pancreatic Cancer
Luo, H., Galvao, D. A., Newton, R. U., López, P., Tang, C., Fairman, C. M., Spry, N. A., & Taaffe, D. R. (2021) · Pancreas · doi:10.1097/mpa.0000000000001753 · Cited by 41
Sarcopenia is an Independent Prognostic Factor in Patients With Pancreatic Cancer – a Meta-analysis
Thormann, M., Hinnerichs, M. S., Ordonez, F. B., Saalfeld, S., Perrakis, A., Croner, R. S., Omari, J., Pech, M., Zamsheva, M., Meyer, H., et al. (2022) · Academic Radiology · doi:10.1016/j.acra.2022.10.025 · Cited by 41
Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia
Delitto, D., Judge, S. M., Delitto, A. E., Nosacka, R. L., Rocha, F. R. G., DiVita, B. B., Gerber, M. H., George, T. J., Behrns, K. E., Hughes, S. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13593 · Cited by 40
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
Hidalgo, M. M., Álvarez-Gallego, R., Gallego-Plazas, J., Guillén‐Ponce, C., Laquente, B., Macarulla, T. M., Muñoz, A., Salgado, M., Vera, R., Adeva, J., et al. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1594-x · Cited by 40
Oncologic impact of preoperative prognostic nutritional index change in resected pancreatic cancer following neoadjuvant chemotherapy
Kim, K. H., Hwang, H. K., Kang, I., Lee, W. J., & Kang, C. M. (2019) · Pancreatology · doi:10.1016/j.pan.2019.12.006 · Cited by 39
Usefulness of Smartphone Apps for Improving Nutritional Status of Pancreatic Cancer Patients: Randomized Controlled Trial
Keum, J., Chung, M. J., Kim, Y., Ko, H., Sung, M. J., Jo, J. H., Park, J. Y., Bang, S., Park, S. W., Song, S. Y., et al. (2021) · JMIR mhealth and uhealth · doi:10.2196/21088 · Cited by 39
Evolving pancreatic cancer treatment: From diagnosis to healthcare management
Milella, M., Bassi, C., Boggi, U., Brunetti, O., Cavaliere, A., Crippa, S., Vita, F. D., Falconi, M., Frassineti, G. L., Giommoni, E., et al. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103571 · Cited by 37
A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients
Fogelman, D. R., Morris, J. S., Xiao, L., Hassan, M., Vadhan‐Raj, S., Overman, M. J., Javle, S., Shroff, R. T., Varadhachary, G. R., Wolff, R. A., et al. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-016-3553-z · Cited by 35
The Relationship Between Nutritional Status, Performance Status, and Survival Among Pancreatic Cancer Patients
Bıçaklı, D. H., Uslu, R., Güney, S. C., & Çöker, A. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1634217 · Cited by 35
The Differential Clinical Impacts of Cachexia and Sarcopenia on the Prognosis of Advanced Pancreatic Cancer
Hou, Y., Chen, C., Huang, C., Wang, C., Chao, Y., Chiang, N., Wang, H., Tung, H., Liu, H., & Shan, Y. (2022) · Cancers · doi:10.3390/cancers14133137 · Cited by 33
Quality of life, symptoms and dietary habits in oncology outpatients with malnutrition: A cross-sectional study
Sonneborn-Papakostopoulos, M., Dubois, C., Mathies, V., Heß, M., Erickson, N. T., Ernst, T., & Hübner, J. (2021) · Medical Oncology · doi:10.1007/s12032-021-01460-7 · Cited by 32
Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus
Carrato, A., Cerezo, L., Feliú, J., Macarulla, T. M., Martín‐Pérez, E., Vera, R., Álvarez, J., & Botella-Carretero, J. I. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02674-x · Cited by 32
Nutrition and Pancreatic Cancer
Phillips, M., & Griffin, O. M. (2021) · Wiley eBooks · doi:10.1002/9781119570097.ch67 · Cited by 32
Pancreatic cancer: Best supportive care
Védié, A., & Neuzillet, C. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.02.032 · Cited by 29
Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy
Şahin, T. K., Özbay, Y., Altunbulak, A. Y., Altunbulak, H. İ., Onur, M. R., Ceylan, F., Güven, D. C., Yalçın, Ş., & Dızdar, Ö. (2024) · International Journal of Clinical Oncology · doi:10.1007/s10147-024-02512-4 · Cited by 27
Associations of Overall Survival with Geriatric Nutritional Risk Index in Patients with Advanced Pancreatic Cancer
Grinstead, C., George, T. J., Han, B., & Yoon, S. L. (2022) · Nutrients · doi:10.3390/nu14183800 · Cited by 26
Supportive care in pancreatic ductal adenocarcinoma
Laquente, B., Calsina-Berna, A., Carmona‐Bayonas, A., Jiménez‐Fonseca, P., Peiró, I., & Carrato, A. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1682-6 · Cited by 26
Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer
Guarneri, G., Pecorelli, N., Bettinelli, A., Campisi, A., Palumbo, D., Genova, L., Gasparini, G., Provinciali, L., Corte, A. D., Abati, M., et al. (2023) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2023.02.005 · Cited by 25
Effect of pretreatment psoas muscle mass on survival for patients with unresectable pancreatic cancer undergoing systemic chemotherapy
Ishii, N. K., Iwata, Y., Nishikawa, H., Enomoto, H., Aizawa, N., Ishii, A., Miyamoto, Y., Yuri, Y., Hasegawa, K., Nakano, C., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.6952 · Cited by 23
Association between early nutritional risk and overall survival in patients with advanced pancreatic cancer: A single-center retrospective study
Park, J. S., Kim, H.-M., Jeung, H., & Kang, S. A. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.01.012 · Cited by 24
Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy
Jin, W. H., Mellon, E. A., Frakes, J. M., Murimwa, G. Z., Hodul, P. J., Pimiento, J. M., Malafa, M. P., & Hoffe, S. E. (2018) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2017.09.13 · Cited by 24
Challenges in Diagnosis and Treatment of Pancreatic Exocrine Insufficiency among Patients with Pancreatic Ductal Adenocarcinoma
Lan, X., Robin, G., Kasnik, J., Wong, G., & Abdel-Rahman, O. M. (2023) · Cancers · doi:10.3390/cancers15041331 · Cited by 22
Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis
Masuda, S., Yamakawa, K., Masuda, A., Toyama, H., Sofue, K., Nanno, Y., Komatsu, S., Omiya, S., Sakai, A., Kobayashi, T., et al. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-13569-2 · Cited by 22
Impact of progressive resistance training on CT quantified muscle and adipose tissue compartments in pancreatic cancer patients
Wochner, R., Clauss, D., Nattenmüller, J., Tjaden, C., Bruckner, T. M., Kauczor, H., Hackert, T., Wiskemann, J., & Steindorf, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242785 · Cited by 22
High SARC-F score predicts poor survival of patients with cancer receiving palliative care
Mori, N., Maeda, K., Fukami, Y., Matsuyama, R., Nonogaki, T., Kato, R., Ishida, Y., Shimizu, A., Ueshima, J., & Nagano, A. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-06845-6 · Cited by 22
Sosiho-tang ameliorates cachexia-related symptoms in mice bearing colon 26 adenocarcinoma by reducing systemic inflammation and muscle loss
Kim, A., Im, M., & Yeul, J. (2015) · Oncology Reports · doi:10.3892/or.2015.4527 · Cited by 20
Impact of the Extent of Weight Loss before Administration on the Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with Cachexia
Takeda, T., Sasaki, T., Okamoto, T., Ishitsuka, T., Yamada, M., Nakagawa, H., Mie, T., Furukawa, T., Kasuga, A., Matsuyama, M., et al. (2022) · Internal Medicine · doi:10.2169/internalmedicine.0730-22 · Cited by 19
Prognostic significance of skeletal muscle decrease in unresectable pancreatic cancer: Survival analysis using the Weibull exponential distribution model
Sato, H., Goto, T., Hayashi, A., Kawabata, H., Okada, T., Takauji, S., Sasajima, J., Enomoto, K., Fujiya, M., Oyama, K., et al. (2021) · Pancreatology · doi:10.1016/j.pan.2021.03.002 · Cited by 19
A Review of Olanzapine in the Treatment of Cancer Anorexia-Cachexia Syndrome
Poon, I. O., Ajewole, V. B., & Braun, U. K. (2024) · Pharmacy · doi:10.3390/pharmacy12010034 · Cited by 18
Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy
Cho, W. K., Yu, J. I., Park, H. C., Lim, D. H., Kim, T. H., & Chie, E. K. (2020) · Tumori Journal · doi:10.1177/0300891620937795 · Cited by 18
CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer
Khristenko, E., Sinitsyn, V. E., Rieden, T., Girod, P., Kauczor, H., Mayer, P., Klauß, M., & Lyadov, V. K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0291185 · Cited by 16
Self-citation
Impact of Baseline Muscle Mass and Myosteatosis on the Development of Early Toxicity During First-Line Chemotherapy in Patients With Initially Metastatic Pancreatic Cancer
Hong, S. I., Kim, K. W., Park, H. J., Ko, Y., Yoo, C., Park, S. Y., Khang, S., Jeong, H., & Lee, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.878472 · Cited by 16
Preoperative sarcopenia is a negative predictor for enhanced postoperative recovery after pancreaticoduodenectomy
Nauheim, D. O., Hackbart, H., Papai, E., Moskal, D., Yeo, C. J., Lavu, H., & Nevler, A. (2022) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-022-02558-w · Cited by 16
Sarcopenia is associated with a greater incidence of delayed gastric emptying following pancreaticoduodenectomy
Tankel, J., Dagan, A., Vainberg, E., Boaz, E., Mogilevsky, L., Hadas‐Halpern, I., Reissman, P., & Ben‐Haim, M. (2018) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2018.05.011 · Cited by 16
Effects of Preoperative Exercise on Physical Fitness and Body Composition in Pancreatic Cancer Survivors Receiving Neoadjuvant Therapy: A Case Series
Marker, R. J., Peters, J. C., Purcell, W. T., & Jankowski, C. M. (2018) · Rehabilitation Oncology · doi:10.1097/01.reo.0000000000000122 · Cited by 15
Sarcopenia: What a Surgeon Should Know
Pinotti, E., Montuori, M., Borrelli, V., Giuffrè, M., & Angrisani, L. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04516-1 · Cited by 16
Does sarcopenia affect outcomes in pediatric surgical patients? A scoping review
Metzger, G. A., Carsel, A., Sebastião, Y. V., Deans, K. J., & Minneci, P. C. (2021) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2021.01.009 · Cited by 16
Impact of Preoperative Malnutrition on Postoperative Long-Term Outcomes of Patients With Pancreatic Head Cancer
Lee, B., Han, H., & Yoon, Y. (2021) · Annals of Surgery Open · doi:10.1097/as9.0000000000000047 · Cited by 16
Treatment of pancreatic insufficiency using pancreatic extract in patients with advanced pancreatic cancer: a pilot study (PICNIC)
Zdenkowski, N., Radvan, G. H., Pugliese, L., Charlton, J. A., Oldmeadow, C. J., Fraser, A., & Bonaventura, A. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3602-2 · Cited by 16
Prediction of clinically relevant pancreatic fistula after pancreatic surgery using preoperative CT scan: A systematic review and meta-analysis
Yue, Y., Li, M., Zhang, X., Yu, H., & Song, B. (2020) · Pancreatology · doi:10.1016/j.pan.2020.09.009 · Cited by 15
Effects of Exercise Training on Patient-Specific Outcomes in Pancreatic Cancer Patients: A Scoping Review
Rosebrock, K., Sinn, M., Uzunoglu, F. G., Bokemeyer, C., Jensen, W., & Salchow, J. L. (2023) · Cancers · doi:10.3390/cancers15245899 · Cited by 14
Impact of TNF-α Gene Polymorphisms on Pancreatic and Non-Small Cell Lung Cancer-Induced Cachexia in Adult Egyptian Patients: A Focus on Pathogenic Trajectories
Yehia, R., Schaalan, M. F., Abdallah, D. M., Saad, A. S., Sarhan, N. M., & Saleh, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.783231 · Cited by 14
Consequences of Increases in Antibiotic Resistance Pattern on Outcome of Pancreatic Resection for Cancer
Gianotti, L. V., Tamini, N., Gavazzi, F., Mariani, A., Sandini, M., Ferla, F., Cereda, M., Capretti, G. L., Sandro, S. D., Bernasconi, D. P., et al. (2017) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-017-3483-1 · Cited by 12
GDF15 and LCN2 for early detection and prognosis of pancreatic cancer
Zhu, X., Olson, B. G., Keith, D., Norgard, M. A., Levasseur, P. R., Diba, P., Protzek, S., Li, J., Li, X., Korzun, T., et al. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102129 · Cited by 15
Evaluation of a Clinic-Based Exercise Program in Patients with Pancreatic Cancer Undergoing Nonsurgical Treatment
Luo, H., Galvao, D. A., Newton, R. U., Tang, C., Hart, N. H., Singh, F., Dean, A. P., Jasas, K., Johansson, M., Yusoff, I. F., et al. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003019 · Cited by 13
Sarcopenia is Independently Associated with an Increased Risk of Peptic Ulcer Disease: A Nationwide Population-Based Study
Choi, Y. I., Chung, J., Park, D. K., Ko, K. P., Kim, K. O., Kwon, K. A., Kim, J. H., & Kim, Y. J. (2020) · Medicina · doi:10.3390/medicina56030121 · Cited by 13
Identification of circulating plasma ceramides as a potential sexually dimorphic biomarker of pancreatic cancer‐induced cachexia
Chakedis, J. M., Dillhoff, M. E., Schmidt, C. R., Rajasekera, P. V., Evans, D. C., Williams, T. M., D, D. C. G., & Talbert, E. E. (2022) · JCSM Rapid Communications · doi:10.1002/rco2.68 · Cited by 12
Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients
Shin, D. W., Kim, M. A., Lee, J.-C., Kim, J., & Hwang, J. (2021) · BMC Research Notes · doi:10.1186/s13104-021-05681-x · Cited by 12
Multidisciplinary Standards and Evolving Therapies for Patients With Pancreatic Cancer
Safyan, R. A., Kim, E., Dekker, E. N., Homs, M. Y. V., Aguirre, A. J., Koerkamp, B. G., & Chiorean, E. G. (2024) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_438598 · Cited by 12
Pancreatic Cancer: Let Us Focus On Cachexia, Not Just Sarcopenia!
Barreto, S. G. (2018) · Future Oncology · doi:10.2217/fon-2018-0369 · Cited by 11
How can we better predict the prognosis of patients with pancreatic cancer undergoing surgery using an immune-nutritional scoring system?
Dang, C., Wang, M., Qin, T., & Qin, R. (2022) · Surgery · doi:10.1016/j.surg.2021.12.009 · Cited by 11
Fat malabsorption in pancreatic cancer: Pathophysiology and management
Murray, G., Ramsey, M. L., Hart, P. A., & Roberts, K. M. (2024) · Nutrition in Clinical Practice · doi:10.1002/ncp.11129 · Cited by 10

Authors: Ozola Zalite, I., Zykus, R., Francisco Gonzalez, M., Saygili, F., Pukitis, A., Gaujoux, S., Charnley, R. M., & Lyadov, V.
Affiliations: Lithuanian University of Health Sciences (LT)
Sorbonne Paris Cité (FR)
Freeman Hospital (GB)
Ministry of Health of the Russian Federation (RU)
Corresponding author: Lyadov, V.
ORCID: Zykus, R.
Gaujoux, S.
Charnley, R.M.
Lyadov, V.
Venue: Pancreatology
Publisher: Elsevier BV
Published: 2015-01
Volume: 15
Issue: 1
Pages: 19-24
ISSN: 1424-3903 (ISSN-L)
DOI: 10.1016/j.pan.2014.11.006
OpenAlex: W2068101666
Cited by: 174
References: 34
Citations by year: 2026: 7 · 2025: 7 · 2024: 15 · 2023: 13 · 2022: 25 · 2021: 25 · 2020: 14 · 2019: 22 · 2018: 17 · 2017: 10 · 2016: 13 · 2015: 6
FWCI: 1.13
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Pancreatology (publishedVersion)
PubMed (publishedVersion)
Lithuanian University of Health Sciences (submittedVersion)
RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
Newcastle University ePrints (Newcastle Univesity)
Funders: Educational and Research Program Pancreas 2000
Topics: Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords: cachexia, sarcopenia, pancreatic ductal adenocarcinoma, survival, skeletal muscle mass, sarcopenic obesity, weight loss, obesity, prognostic factors, inflammatory markers
MeSH terms: Cachexia, Humans, Pancreatic Neoplasms, Prognosis, Weight Loss, Prevalence, Survival Rate, Carcinoma, Pancreatic Ductal, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks